Company: PTPI
Filing Date: 2025-02-13
Form Type: S-1/A
Source: 0001410578-25-000122
Chunk: 228

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-02-13
Form: S-1/A
Chunk 228
---
 |
| 2024                              |   | ​                | 155,242 |
| 2025                              | ​ | ​                |  81,107 |
| 2026                              | ​ | ​                |  82,325 |
| Total lease payments              |   | ​                | 318,674 |
| Less: Imputed Interest            |   | ​                | -55,997 |
| Total                             | ​ | $                | 262,677 |

Future minimum sublease income under non-cancelable leases as of December 31, 2023, were as follows:

| ​               
 Sublease income | ​ | ​                
 Operating Leases |      ​ |
|:----------------|:--|:-----------------|-------:|
| 2024            | ​ | $                | 56,000 |
| ​               | ​ | ​                |      ​ |
| Total           | ​ | $                | 56,000 |

As of December 31, 2023, and 2022, the Company hadnooperating leases that had not yet commenced.

F-19

10) Stockholders’ Equity On December 21, 2023, the Company approved a one-time grant under the Company’s Amended and Restated 2020 Omnibus Incentive Compensation Plan (the “Plan”) to Fady Boctor, the Company’s President and Chief Commercial Officer, of 49,645shares of the Company’s common stock. Also on December 21, 2023, the Company approved and accrued for the issuance of $ 200,000of common stock, payable in twoequal installments, with the first installment to be paid upon approval by the Board and the second installment six months after the first installment, to CorProminence, LLC (“CoreIR”) for services rendered pursuant to a Marketing and Consulting Agreement. The first installment of 70,922shares was issued on February 29, 2024. Contingent Consideration Pursuant to the Merger Agreement, each security holder of Metuchen received a right to receive such security holder’s pro rata stock of an aggregate of 1,423,209shares of Petros Common Stock potentially issuable upon the achievement of certain milestones set forth in the Merger Agreement. The milestones are for the achievement of stock price and market capitalization, as defined over a two-yearperiod. Market Capitalization/Gross Proceeds Earnout Payments In connection with the Mergers, each security holder of